CNL Launches Program to Accelerate the Development of Targeted Radiopharmaceuticals in Canada


The Canadian Nuclear Laboratory is successfully developing the Canadian Nuclear Research Initiative to integrate health sciences.

Content of the article

CHALK RIVER, Ontario, Nov. 25, 2021 (GLOBE NEWSWIRE) – The Canadian Nuclear Laboratories (CNL), Canada’s largest nuclear science and technology organization, is pleased to announce that it has offered an invitation to the idea of ​​a new “healthy river” inside. The Canadian Nuclear Research Initiative (CNRI). The new program was designed to advance the development of affected radiopharmaceuticals in Canada through research projects related to health sciences, radiobiology and medical isotope development, by providing access to world-class laboratories and research technology at the Chalk camp. River Laboratories.

Advertising

Content of the article

Established in 2019, the CNRI program was initially established by the CNL to promote the deployment of small modular processors (SMRs) and advanced reactor design. Continued interest in the program has enabled CNL to develop CNRI in health sciences, another important technical component, allowing students to access the company’s unique position and staff to conduct research in collaboration with CNL.

“With the more than one billion medical care made using isotopes manufactured at Chalk River Laboratories, CNL’s work has touched the lives of people all over the world,” said Joe McBrearty, President and CEO of CNL. “Today, we continue to work as a fully-fledged nuclear laboratory capable of developing advanced medical technology, as well as a wide range of radiochemical surveillance. I’m really looking forward to cancer treatment. “

Advertising

Content of the article

For the initial diet of the program, research ideas should be linked to topics that include delivery strategies, toxicology and clinical evaluation. Once the technical review of each idea has been completed, CNL will work with the representative to develop a plan for setting the size, budget, and potential implications of the project. The CNL will complete a final review of the proposed applications before selecting and approving the successful ones. The deadline for submissions is January 15, 2022, and projects will be selected by the end of 2022.

As a global leader in medical isotopes and research related to over 70 years, CNL has pioneered the use of the Cobalt-60 drug in the treatment of cancer, and has served as the world’s largest producer of Molybdenum-99, which. they are used in monitoring methods. CNL now has a wide range of capabilities in the fields of health and dosimetry, including pre-animal studies, isotope production and processing, chemical testing in glass, radionuclide correction, ISO-certified monitoring functions and waste management techniques.

Advertising

Content of the article

“The CNRI program has been very successful in developing SMRs and other advanced rector technologies, and encouraged us to use this model in other areas of our research,” said Dr. Jeff Griffin, Vice President of CNL Science & Technology. . “We believe that there is an insufficient need for organizations to pursue radiopharmaceutical research, toxicology and clinical research prior to hospitalization, and that this program could be a way to improve solutions in these areas.”

Outside of CNRI, CNL is working to establish itself as a global center for the research, development and delivery of next-generation medical isotopes and radiopharmaceuticals, including Actinium-225, a rare isotope that demonstrates great promise as a new, cost-effective cancer treatment of the edge. As part of this effort, CNL will soon signed a Memorandum of Understanding with ITM Isotope Technologies Munich SE Actinium-225 industrial development and manufacturing research.

Advertising

Content of the article

To learn more about CNL and its role in health sciences, please visit www.cnl.ca/health . To learn more about CNRI Health Stream, including instructions and details, please visit www.cnl.ca/cnri -health.

For CNL
Canadian Nuclear Laboratories is a global leader in nuclear science and technology, providing unique capabilities and solutions in a variety of industries. With a strong focus on industrial research and development of nuclear weapons, operations, technology, energy, security, security and life sciences, we provide solutions to these sectors to compete globally.

With the money flowing into new locations and a more stable position, Canadian Nuclear Laboratories is a bright future. A new standard of practice promoted by a strong security culture ensures all-inclusive.

For more information on all types of Canadian Nuclear Laboratories, please visit www.cnl.ca or contact [email protected] .

Contact CNL:
Patrick Quinn
Director, Corporate Communications
Phone: 1-866-886-2325
Email: [email protected]

The accompanying photo is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/869ef61d-4a19-4c86-93d9-47ca287adbd3

Original logo

Advertising

Comments

Postmedia is committed to maintaining a fun but casual discussion forum and encourages all readers to share their thoughts on our posts. Comments may take up to an hour to appear on the page. We invite you to make your comments relevant and respectful. We have opened email notifications — you will receive a reply to your comment, there are changes to the comment thread you follow or if you follow the comment. Go home Community Guidelines to hear more and more about how to change email settings.


Original Article reposted fromSource link

Disclaimer: The website autopost contents from credible news sources and we are not the original creators. If we Have added some content that belongs to you or your organization by mistake, We are sorry for that. We apologize for that and assure you that this won’t be repeated in future. If you are the rightful owner of the content used in our Website, please mail us with your Name, Organization Name, Contact Details, Copyright infringing URL and Copyright Proof (URL or Legal Document) aT spacksdigital @ gmail.com

I assure you that, I will remove the infringing content Within 48 Hours.

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Sodexo Live! Unveils Slate of Big-Game Menu Items and Local Suppliers for the 108th Grey Cup at Tim Hortons Field

Breadcrumb Trail links GlobeNewswire Reporter: Date of publication: Dec 07, 2021 • 13 minutes ago • 3 minutes reading • Join in the discussion Content of the article HAMILTON, Ontario, Dec. 07, 2021 (GLOBE NEWSWIRE) – Sodexo Live !, hostess Tim Hortons Field (THF) with many of the most famous places in the world, today […]

Read More
Business

Share Market LIVE: Sensex closes 886 pts higher at 57,633, Nifty adds 264 pts to end at 17,176

India VIX was very red. (Photo: REUTERS) Share Market News Today | Sensex, Nifty, Share Prices LIVE: Domestic markets traded with profits on Tuesday, looking to reverse some of the losses suffered in the past several years. S&P Ideas for the company BSE Sensex got 900 points to get 57,600 points right Nifty 50 was […]

Read More
Business

£85k limit on bank customers’ protection ‘is enough’, says City watchdog

There should be no increase in the amount of money that customers can repay if their banks, real estate agencies or other investment companies collapse, says City watchdog. The Financial Conduct Authority says it believes the current £ 85,000 is enough to deal with most cases. However, it said that the rate should be monitored […]

Read More